PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)

IDX:OBAT Revenue

PT Brigit Biofarmaka Technologi Tbk had revenue of 45.18B IDR in the quarter ending June 30, 2026, a decrease of -4.98%. This brings the company's total for the last twelve months to 172.56B, up 21.15% year-over-year. In the year 2025, PT Brigit Biofarmaka Technologi Tbk had annual revenue of 160.12B with 32.74% growth. That makes PT Brigit Biofarmaka Technologi Tbk the 37,604th largest company in the world by revenue and 679th in Indonesia.

• Revenue (ttm): 172.56B
• Revenue Growth: +21.15%
• P/S Ratio: 0.94
• Revenue / Employee: 10.15B
• Employees: 17
• Market Cap: 161.93B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Herbal 92.69B 57.9%
• Cosmetics 36.97B 23.1%
• Functional and Botanical Drinks 30.46B 19.0%

Fiscal year ended Dec 31, 2025 See the full IDX:OBAT breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	160.12B	39.49B	32.74%
Dec 31, 2024	120.63B	63.70B	111.89%
Dec 31, 2023	56.93B	18.43B	47.89%
Dec 31, 2022	38.50B	642.48M	1.70%
Dec 31, 2021	37.85B	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error